Related references
Note: Only part of the references are listed.Non-Photoinduced Biological Properties of Verteporfin
Floriane Gibault et al.
CURRENT MEDICINAL CHEMISTRY (2016)
The global health dimensions of asbestos and asbestos-related diseases
Ken Takahashi
JOURNAL OF OCCUPATIONAL HEALTH (2016)
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma
Mayura Meerang et al.
MOLECULAR ONCOLOGY (2016)
YAP promotes erlotinib resistance in human non-small cell lung cancer cells
Ping-Chih Hsu et al.
ONCOTARGET (2016)
Hippo Pathway Gene Mutations in Malignant Mesothelioma Revealed by RNA and Targeted Exon Sequencing
Akihiko Miyanaga et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
Huabing Zhang et al.
SCIENCE SIGNALING (2015)
Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1
Huabing Zhang et al.
SCIENCE SIGNALING (2015)
LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade
I. Tanaka et al.
ONCOGENE (2015)
Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
Fa-Xing Yu et al.
CANCER CELL (2014)
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
Xiaodong Feng et al.
CANCER CELL (2014)
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Katarzyna Brodowska et al.
EXPERIMENTAL EYE RESEARCH (2014)
Role of Hippo Signaling in Cancer Stem Cells
Jin Hao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
CTGF is a therapeutic target for metastatic melanoma
E. C. Finger et al.
ONCOGENE (2014)
Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
Elizabeth Donohue et al.
PLOS ONE (2014)
Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
Su-xia Han et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
The Hippo pathway in disease and therapy: cancer and beyond
Marta Gomez et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2014)
RASSF1A-Mediated Regulation of AREG via the Hippo Pathway in Hepatocellular Carcinoma
Ei Yong Ahn et al.
MOLECULAR CANCER RESEARCH (2013)
Regulation of the Hippo pathway and implications for anticancer drug development
Hyun Woo Park et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma
Mitchell Cheung et al.
CANCER GENETICS (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma TGFβ signaling and defects in the Hippo signaling cascade
Makiko Fujii et al.
CELL CYCLE (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)
Jung-Soon Mo et al.
GENES & DEVELOPMENT (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
Bin Zhao et al.
GENES & DEVELOPMENT (2012)
TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Makiko Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis
Sheelu Varghese et al.
PLOS ONE (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
Hideki Murakami et al.
CANCER RESEARCH (2011)
The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma
Tong Li et al.
JOURNAL OF PATHOLOGY (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation
Yoshitaka Sekido
PATHOLOGY INTERNATIONAL (2011)
Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells
Yoshitaka Sekido
CANCER SCIENCE (2010)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
The Hippo Signaling Pathway in Development and Cancer
Duojia Pan
DEVELOPMENTAL CELL (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease
Kainan Wang et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2009)
Transcriptional Output of the Salvador/Warts/Hippo Pathway Is Controlled in Distinct Fashions in Drosophila melanogaster and Mammalian Cell Lines
Xiaomeng Zhang et al.
CANCER RESEARCH (2009)
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Mark Shackleton et al.
CELL (2009)
The Hippo Signaling Pathway Components Lats and Yap Pattern Tead4 Activity to Distinguish Mouse Trophectoderm from Inner Cell Mass
Noriyuki Nishioka et al.
DEVELOPMENTAL CELL (2009)
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
Haining Yang et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2008)
YAP regulates neural progenitor cell number via the TEA domain transcription factor
Xinwei Cao et al.
GENES & DEVELOPMENT (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Connective tissue growth factor (CTGF) and cancer progression
Chia-Yu Chu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2008)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
JP van Meerbeeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
